Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds
Journal of the American Podiatric Medical Association · 2024
DOI: 10.7547/22-132 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the American Podiatric Medical Association, 2024. Verfasst von Ahmed Gamal und 5 weiteren Autor:innen. Beteiligte Einrichtung: *Center for Medical Mycology, and Integrated Microbiome Core, Department of Dermatology, Case Western Reserve University, Cleveland, OH. Hauptthemen laut MEDLINE: Antifungal Agents, Itraconazole, Microbial Sensitivity Tests, Fluconazole. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Background
Recently, an increasing number of resistant-to-terbinafine dermatophytosis cases have been reported. Thus, identifying an alternative antifungal agent that possesses broad-spectrum activity, including against resistant strains, is needed.
Methods
We compared the antifungal activity of efinaconazole with that of fluconazole, itraconazole, and terbinafine against clinical isolates of dermatophytes, Candida , and molds using in vitro assays. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of each antifungal agent were quantified and compared. Susceptible and resistant clinical isolates of Trichophyton mentagrophytes (n = 16), Trichophyton rubrum (n = 43), Trichophyton tonsurans (n = 18), Trichophyton violaceum (n = 4), Candida albicans (n = 55), Candida auris (n = 30), Fusarium spp, Scedosporium spp, and Scopulariopsis spp (n = 15 for each) were tested.
Results
Efinaconazole was the most active antifungal agent tested against dermatophytes, with MIC 50 and MIC 90 (concentrations that inhibited 50% and 90% of strains tested, respectively) values of 0.002 and 0.03 µg/mL, respectively. Fluconazole, itraconazole, and terbinafine showed MIC 50 and MIC 90 values of 1 and 8 µg/mL, 0.03 and 0.25 µg/mL, and 0.03 and 16 µg/mL, respectively. Against Candida isolates, efinaconazole MIC 50 and MIC 90 values were 0.016 and 0.25 µg/mL, respectively, whereas fluconazole, itraconazole, and terbinafine had MIC 50 and MIC 90 values of 1 and 16 µg/mL, 0.25 and 0.5 µg/mL, and 2 and 8 µg/mL, respectively. Against various mold species, efinaconazole MIC values ranged from 0.016 to 2 µg/mL versus 0.5 to greater than 64 µg/mL for the comparators.
Conclusions
Efinaconazole showed superior potent activity against a broad panel of susceptible and resistant dermatophyte, Candida , and mold isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- *Center for Medical Mycology, and Integrated Microbiome Core, Department of Dermatology, Case Western Reserve University, Cleveland, OH.
- †Clinical Pathology Department, Mansoura University Faculty of Medicine, Mansoura, Egypt.
- ‡Department of Dermatology, University of Birmingham, Birmingham, AL.
- §University Hospitals Cleveland Medical Center, Cleveland, OH.
Zitieren
APA
Gamal, A., Elshaer, M., Long, L., McCormick, T. S., Elewski, B., & Ghannoum, M. A. (2024). Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/22-132
Vancouver
Gamal A, Elshaer M, Long L, McCormick TS, Elewski B, Ghannoum MA. Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds. Journal of the American Podiatric Medical Association. 2024. doi:10.7547/22-132
BibTeX
@article{Gamal2024,
author = {Gamal, Ahmed and Elshaer, Mohammed and Long, Lisa and McCormick, Thomas S and Elewski, Boni and Ghannoum, Mahmoud A},
title = {Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds},
journal = {Journal of the American Podiatric Medical Association},
year = {2024},
doi = {10.7547/22-132}
}
EUVIMED